Stem Cell Autograft Minimal Residual Disease Negativity Improves Outcomes after Autotransplant for Multiple Myeloma

被引：1

作者：

Nishimura, Noriko ^{[1
]}

Brown, Samantha ^{[2
]}

Devlin, Sean M. ^{[3
]}

Dahi, Parastoo B. ^{[4
,5
]}

Landau, Heather ^{[4
,6
]}

Lahoud, Oscar B. ^{[6
]}

Scordo, Michael ^{[4
,6
]}

Shah, Gunjan L. ^{[4
,7
]}

Hassoun, Hani ^{[8
]}

Hultcrantz, Malin ^{[8
]}

Korde, Neha ^{[8
]}

Lesokhin, Alexander M. ^{[5
,9
]}

Mailankody, Sham ^{[5
]}

Shah, Urvi A. ^{[8
]}

Tan, Carlyn ^{[8
]}

Usmani, Saad ^{[10
]}

Giralt, Sergio A. ^{[4
,11
]}

Chung, David J. ^{[4
,6
]}

Gupta, Gaurav ^{[12
]}

Maryamchik, Elena ^{[12
]}

Ntrivalas, Evangelos ^{[13
]}

Roshal, Mikhail ^{[14
]}

机构：

[1] Sloan Kettering Inst Canc Res, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol Biostat, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA

[4] Weill Cornell Med Coll, Dept Med, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, Cellular Therapy Serv, 1275 York Ave, New York, NY 10021 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[9] Weill Cornell Med Coll, New York, NY USA

[10] Levine Canc Inst, New York, NY USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Transfus Med & Cell Therapy, 1275 York Ave, New York, NY 10021 USA

[13] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Cellular Immunol Serv, 1275 York Ave, New York, NY 10021 USA

[14] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, 1275 York Ave, New York, NY 10021 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma
Bal, Susan
Landau, Heather J.
Shah, Gunjan L.
Scordo, Michael
Dahi, Parastoo
Lahoud, Oscar B.
Hassoun, Hani
Hultcrantz, Malin
Korde, Neha
Lendvai, Nikoletta
Lesokhin, Alexander M.
Mailankody, Sham
Shah, Urvi A.
Smith, Eric
Devlin, Sean M.
Avecilla, Scott
Dogan, Ahmet
Roshal, Mikhail
Landgren, Ola
Giralt, Sergio A.
Chung, David J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1394 - 1401
[2] Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma
Chu, Michael P.
Baigorri, Eva
Kriangkum, Jitra
Hewitt, Joanne D.
Belch, Andrew
Venner, Christopher P.
Sandhu, Irwindeep
Pilarski, Linda M.
BLOOD, 2017, 130
[3] Minimal residual disease testing after stem cell transplantation for multiple myeloma
A M Sherrod
P Hari
C A Mosse
R C Walker
R F Cornell
Bone Marrow Transplantation, 2016, 51 : 2 - 12
[4] Minimal residual disease testing after stem cell transplantation for multiple myeloma
Sherrod, A. M.
Hari, P.
Mosse, C. A.
Walker, R. C.
Cornell, R. F.
BONE MARROW TRANSPLANTATION, 2016, 51 (01) : 2 - 12
[5] Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma
Patel, Dilan A.
Gopalakrishnan, Ragisha
Engelhardt, Brian G.
McArthur, Evonne
Sengsayadeth, Salyka
Culos, Katie A.
Byrne, Michael
Goodman, Stacey
Savani, Bipin N.
Chinratanalab, Wichai
Jagasia, Madan
Mosse, Claudio A.
Cornell, Robert F.
Kassim, Adetola A.
BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1137 - 1146
[6] Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma
Dilan A. Patel
Ragisha Gopalakrishnan
Brian G. Engelhardt
Evonne McArthur
Salyka Sengsayadeth
Katie A. Culos
Michael Byrne
Stacey Goodman
Bipin N. Savani
Wichai Chinratanalab
Madan Jagasia
Claudio A. Mosse
Robert F. Cornell
Adetola A. Kassim
Bone Marrow Transplantation, 2020, 55 : 1137 - 1146
[7] Monitoring of minimal residual disease among multiple myeloma patients after autologous stem cell transplantation
Akhundova, F.
Mendeleeva, L.
Galtseva, I.
Pokrovskaya, O.
Urnova, E.
Parovichnikova, E.
Savchenko, V.
BONE MARROW TRANSPLANTATION, 2012, 47 : S258 - S259
[8] Multiple myeloma: Maintenance therapy after autologous stem cell transplantation, depending on minimal residual disease
Solovyev, M. V.
Mendeleeva, L. P.
Pokrovskaya, O. S.
Nareyko, M. V.
Firsova, M. V.
Galtseva, I. V.
Davydova, Yu. O.
Kapranov, N. M.
Kuzmina, L. A.
Gemdzhian, E. G.
Savchenko, V. G.
TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 25 - 31
[9] Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
Pianko, Matthew J.
Devlin, Sean M.
Littmann, Eric R.
Chansakul, Aisara
Mastey, Donna
Salcedo, Meghan
Fontana, Emily
Line, Lilan
Tavitian, Elizabet
Slingerland, John B.
Slingerland, Ann E.
Clurman, Annelie
Gomes, Antonio L. C.
Taur, Ying
Pamer, Eric G.
Peled, Jonathan U.
van den Brink, Marcel R. M.
Landgren, Ola
Lesokhin, Alexander M.
BLOOD ADVANCES, 2019, 3 (13) : 2040 - 2044
[10] Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma
Campbell, Lauren
Panitsas, Fotios
Basu, Supratik
Anyanwu, Francis
Lee, Sophie
Ferry, Berne
Ramasamy, Karthik
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 775 - 778

← 1 2 3 4 5 →